Mark Juckett named medical director of the Masonic’s immuno-oncology initiative

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Mark Juckett was named medical director of the Masonic Cancer Center Clinical Trials Office for the Cellular, Gene and Immunotherapy Initiative (CTO-CGI). 

To access this subscriber-only content please log in or renew you subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
In This Issue

YOU MAY BE INTERESTED IN

Login